Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 308

1.

To What Target Hemoglobin A1c Level Would You Treat This Patient With Type 2 Diabetes?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.

Smetana GW, Nathan DM, Dugdale DC, Burns RB.

Ann Intern Med. 2019 Oct 1;171(7):505-513. doi: 10.7326/M19-0946.

PMID:
31569249
2.

Association of Concussion Symptoms With Testosterone Levels and Erectile Dysfunction in Former Professional US-Style Football Players.

Grashow R, Weisskopf MG, Miller KK, Nathan DM, Zafonte R, Speizer FE, Courtney TK, Baggish A, Taylor HA, Pascual-Leone A, Nadler LM, Roberts AL.

JAMA Neurol. 2019 Aug 26. doi: 10.1001/jamaneurol.2019.2664. [Epub ahead of print]

3.

Rationale and Design for a GRADE Substudy of Continuous Glucose Monitoring.

Larkin ME, Nathan DM, Bebu I, Krause-Steinrauf H, Herman WH, Higgins JM, Tiktin M, Cohen RM, Lund C, Bergenstal RM, Johnson ML, Arends V; GRADE Research Group.

Diabetes Technol Ther. 2019 Dec;21(12):682-690. doi: 10.1089/dia.2019.0202. Epub 2019 Sep 4.

PMID:
31393176
4.

Does diabetes prevention translate into reduced long-term vascular complications of diabetes?

Nathan DM, Bennett PH, Crandall JP, Edelstein SL, Goldberg RB, Kahn SE, Knowler WC, Mather KJ, Mudaliar S, Orchard TJ, Temprosa M, White NH; Research Group.

Diabetologia. 2019 Aug;62(8):1319-1328. doi: 10.1007/s00125-019-4928-8. Epub 2019 Jul 4. Review.

PMID:
31270584
5.

Accuracy of a Point-of-Care Hemoglobin A1c Assay.

Nathan DM, Griffin A, Perez FM, Basque E, Do L, Steiner B.

J Diabetes Sci Technol. 2019 Nov;13(6):1149-1153. doi: 10.1177/1932296819836101. Epub 2019 Apr 3.

PMID:
30943787
6.

The Need for Accuracy in Hemoglobin A1c Proficiency Testing: Why the Proposed CLIA Rule of 2019 Is a Step Backward.

Klonoff DC, Aron D, Cohen RM, Home P, John WG, Little RR, Nathan DM, Sacks DB.

J Diabetes Sci Technol. 2019 May;13(3):424-427. doi: 10.1177/1932296819841699. Epub 2019 Mar 22. No abstract available.

PMID:
30897963
7.

Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes.

Calderon Moreno R, Navas-Acien A, Escolar E, Nathan DM, Newman J, Schmedtje JF, Diaz D, Lamas GA, Fonseca V.

J Clin Endocrinol Metab. 2019 Jul 1;104(7):2931-2941. doi: 10.1210/jc.2018-01484.

PMID:
30869793
8.

Comparative Studies on the Aqueous Synthesis and Biocompatibility of L-Cysteine and Mercaptopropionic Acid Capped CdSe/CdS/ZnS Core/Shell/Shell Quantum Dots.

Sukanya D, Nathan DMGT, Mahesh R, Sagayaraj P.

J Nanosci Nanotechnol. 2019 Jun 1;19(6):3334-3342. doi: 10.1166/jnn.2019.16095.

PMID:
30744761
9.

Islet autoantibody positivity in overweight and obese adults with type 2 diabetes.

Pilla SJ, Balasubramanyam A, Knowler WC, Lazo M, Nathan DM, Pi-Sunyer X, Clark JM, Maruthur NM; Look AHEAD Research Group.

Autoimmunity. 2018 Dec;51(8):408-416. doi: 10.1080/08916934.2018.1547711. Epub 2019 Jan 2.

PMID:
30661481
10.

Guidelines Versus Guidelines.

Draznin B, Nathan DM, Korytkowski MT, McDonnell ME, Golden SH, Schutta MH, Cefalu WT.

Ann Intern Med. 2018 Dec 18;169(12):896-897. doi: 10.7326/L18-0560. No abstract available.

PMID:
30557433
11.

Diagnosing diabetes mellitus - best practices still unclear.

Nathan DM.

Nat Rev Endocrinol. 2018 Oct;14(10):572-573. doi: 10.1038/s41574-018-0072-7. No abstract available.

PMID:
30054564
12.

Guidelines Versus Guidelines: What's Best for the Patient?

Draznin B, Nathan DM, Korytkowski MT, McDonnell ME, Golden SH, Schutta MH, Cefalu WT.

Ann Intern Med. 2018 Aug 7;169(3):186-187. doi: 10.7326/M18-0939. Epub 2018 May 22. No abstract available.

PMID:
29800101
13.

Estimating HbA1c from timed Self-Monitored Blood Glucose values.

Fan W, Zheng H, Wei N, Nathan DM.

Diabetes Res Clin Pract. 2018 Jul;141:56-61. doi: 10.1016/j.diabres.2018.04.023. Epub 2018 Apr 16.

PMID:
29673846
14.

Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.

Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS, Craft S, Gandy S, Buettner C, Stoeckel LE, Holtzman DM, Nathan DM.

Nat Rev Neurol. 2018 Mar;14(3):168-181. doi: 10.1038/nrneurol.2017.185. Epub 2018 Jan 29. Review.

15.

Response to Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777-783.

Lachin JM, Bebu I, Bergenstal RM, Pop-Busui R, Service FJ, Zinman B, Nathan DM; DCCT/EDIC Research Group.

Diabetes Care. 2017 Nov;40(11):e165-e166. doi: 10.2337/dci17-0038. No abstract available.

16.

Physical Function Following a Long-Term Lifestyle Intervention Among Middle Aged and Older Adults With Type 2 Diabetes: The Look AHEAD Study.

Houston DK, Neiberg RH, Miller ME, Hill JO, Jakicic JM, Johnson KC, Gregg EW, Hubbard VS, Pi-Sunyer X, Rejeski WJ, Wing RR, Bantle JP, Beale E, Berkowitz RI, Cassidy-Begay M, Clark JM, Coday M, Delahanty LM, Dutton G, Egan C, Foreyt JP, Greenway FL, Hazuda HP, Hergenroeder A, Horton ES, Jeffery RW, Kahn SE, Kure A, Knowler WC, Lewis CE, Martin CK, Michaels S, Montez MG, Nathan DM, Patricio J, Peters A, Pownall H, Regensteiner J, Steinburg H, Wadden TA, White K, Yanovski SZ, Zhang P, Kritchevsky SB.

J Gerontol A Biol Sci Med Sci. 2018 Oct 8;73(11):1552-1559. doi: 10.1093/gerona/glx204.

17.

Adjunctive Treatments for Type 1 Diabetes.

Nathan DM.

N Engl J Med. 2017 Dec 14;377(24):2390-2391. doi: 10.1056/NEJMe1711296. Epub 2017 Sep 13. No abstract available.

PMID:
28899219
18.

Rate of Change of Premeal Glucose Measured by Continuous Glucose Monitoring Predicts Postmeal Glycemic Excursions in Patients With Type 1 Diabetes: Implications for Therapy.

Majithia AR, Wiltschko AB, Zheng H, Walford GA, Nathan DM.

J Diabetes Sci Technol. 2018 Jan;12(1):76-82. doi: 10.1177/1932296817725756. Epub 2017 Sep 4.

19.

A computational model of 1,5-AG dynamics during pregnancy.

Zekavat SM, Butkovich S, Young GJ, Nathan DM, Petrasek D.

Physiol Rep. 2017 Aug;5(16). pii: e13375. doi: 10.14814/phy2.13375.

20.

Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.

Aroda VR, Knowler WC, Crandall JP, Perreault L, Edelstein SL, Jeffries SL, Molitch ME, Pi-Sunyer X, Darwin C, Heckman-Stoddard BM, Temprosa M, Kahn SE, Nathan DM; Diabetes Prevention Program Research Group.

Diabetologia. 2017 Sep;60(9):1601-1611. doi: 10.1007/s00125-017-4361-9. Epub 2017 Aug 2. Review.

21.

The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT/EDIC study.

Bebu I, Braffett BH, Pop-Busui R, Orchard TJ, Nathan DM, Lachin JM; DCCT/EDIC Research Group.

Diabetologia. 2017 Oct;60(10):2084-2091. doi: 10.1007/s00125-017-4374-4. Epub 2017 Jul 16.

22.

Frequency of Evidence-Based Screening for Diabetic Retinopathy.

Nathan DM, Bebu I, Lachin JM.

N Engl J Med. 2017 Jul 13;377(2):195. doi: 10.1056/NEJMc1706322. No abstract available.

PMID:
28700836
23.

The Effect of Intentional Weight Loss on Fracture Risk in Persons With Diabetes: Results From the Look AHEAD Randomized Clinical Trial.

Johnson KC, Bray GA, Cheskin LJ, Clark JM, Egan CM, Foreyt JP, Garcia KR, Glasser S, Greenway FL, Gregg EW, Hazuda HP, Hergenroeder A, Hill JO, Horton ES, Jakicic JM, Jeffery RW, Kahn SE, Knowler WC, Lewis CE, Miller M, Montez MG, Nathan DM, Patricio JL, Peters AL, Pi-Sunyer X, Pownall HJ, Reboussin D, Redmon JB, Steinberg H, Wadden TA, Wagenknecht LE, Wing RR, Womack CR, Yanovski SZ, Zhang P, Schwartz AV; Look AHEAD Study Group.

J Bone Miner Res. 2017 Nov;32(11):2278-2287. doi: 10.1002/jbmr.3214. Epub 2017 Jul 28.

24.

Effect of a long-term intensive lifestyle intervention on prevalence of cognitive impairment.

Espeland MA, Luchsinger JA, Baker LD, Neiberg R, Kahn SE, Arnold SE, Wing RR, Blackburn GL, Bray G, Evans M, Hazuda HP, Jeffery RW, Wilson VM, Clark JM, Coday M, Demos-McDermott K, Foreyt JP, Greenway F, Hill JO, Horton ES, Jakicic JM, Johnson KC, Knowler WC, Lewis CE, Nathan DM, Peters A, Pi-Sunyer X, Pownall H, Wadden TA, Rapp SR; Look AHEAD Study Group.

Neurology. 2017 May 23;88(21):2026-2035. doi: 10.1212/WNL.0000000000003955. Epub 2017 Apr 26.

25.

Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.

DCCT/EDIC Research Group, Nathan DM, Bebu I, Hainsworth D, Klein R, Tamborlane W, Lorenzi G, Gubitosi-Klug R, Lachin JM.

N Engl J Med. 2017 Apr 20;376(16):1507-1516. doi: 10.1056/NEJMoa1612836.

26.

Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial.

Lachin JM, Bebu I, Bergenstal RM, Pop-Busui R, Service FJ, Zinman B, Nathan DM; DCCT/EDIC Research Group.

Diabetes Care. 2017 Jun;40(6):777-783. doi: 10.2337/dc16-2426. Epub 2017 Apr 12.

27.

Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes Organizations.

Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, Del Prato S, Ji L, Sadikot SM, Herman WH, Amiel SA, Kaplan LM, Taroncher-Oldenburg G, Cummings DE; Delegates of the 2nd Diabetes Surgery Summit.

Obes Surg. 2017 Jan;27(1):2-21. doi: 10.1007/s11695-016-2457-9.

PMID:
27957699
28.

Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial.

Look AHEAD Research Group, Gregg EW, Jakicic JM, Blackburn G, Bloomquist P, Bray GA, Clark JM, Coday M, Curtis JM, Egan C, Evans M, Foreyt J, Foster G, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jeffery RW, Johnson KC, Kitabchi AE, Knowler WC, Kriska A, Lang W, Lewis CE, Montez MG, Nathan DM, Neiberg RH, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Redmon B, Regensteiner J, Rejeski J, Ribisl PM, Safford M, Stewart K, Trence D, Wadden TA, Wing RR, Yanovski SZ.

Lancet Diabetes Endocrinol. 2016 Nov;4(11):913-921. doi: 10.1016/S2213-8587(16)30162-0. Epub 2016 Aug 30.

29.
30.

Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations.

Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, Del Prato S, Ji L, Sadikot SM, Herman WH, Amiel SA, Kaplan LM, Taroncher-Oldenburg G, Cummings DE; Delegates of the 2nd Diabetes Surgery Summit.

Surg Obes Relat Dis. 2016 Jul;12(6):1144-62. doi: 10.1016/j.soard.2016.05.018.

PMID:
27568469
31.

Preventing Diabetic Retinopathy Progression.

Ferris FL 3rd, Nathan DM.

Ophthalmology. 2016 Sep;123(9):1840-2. doi: 10.1016/j.ophtha.2016.05.039. No abstract available.

PMID:
27549874
32.

Eulogy for the clinical research center.

Nathan DG, Nathan DM.

J Clin Invest. 2016 Jul 1;126(7):2388-91. doi: 10.1172/JCI88381. Epub 2016 Jun 6.

33.

Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications.

Adams TD, Arterburn DE, Nathan DM, Eckel RH.

Diabetes Care. 2016 Jun;39(6):912-23. doi: 10.2337/dc16-0157. Review.

34.

Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations.

Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, Del Prato S, Ji L, Sadikot SM, Herman WH, Amiel SA, Kaplan LM, Taroncher-Oldenburg G, Cummings DE; Delegates of the 2nd Diabetes Surgery Summit.

Diabetes Care. 2016 Jun;39(6):861-77. doi: 10.2337/dc16-0236.

PMID:
27222544
35.

Association between body weight and composition and plasma 25-hydroxyvitamin D level in the Diabetes Prevention Program.

Ceglia L, Nelson J, Ware J, Alysandratos KD, Bray GA, Garganta C, Nathan DM, Hu FB, Dawson-Hughes B, Pittas AG; Diabetes Prevention Program Research Group.

Eur J Nutr. 2017 Feb;56(1):161-170. doi: 10.1007/s00394-015-1066-z. Epub 2015 Nov 2.

36.

Data sharing is desirable, but benefits should not be exaggerated.

Nathan DM, Genuth SM, Zinman B, Lachin JM.

BMJ. 2015 Oct 21;351:h5508. doi: 10.1136/bmj.h5508. No abstract available.

PMID:
26489751
37.

Diabetes: Advances in Diagnosis and Treatment.

Nathan DM.

JAMA. 2015 Sep 8;314(10):1052-62. doi: 10.1001/jama.2015.9536. Review. Erratum in: JAMA. 2015 Dec 22-29;314(24):2693.

PMID:
26348754
38.

Improving diabetes outcomes through lifestyle change--A randomized controlled trial.

Delahanty LM, Dalton KM, Porneala B, Chang Y, Goldman VM, Levy D, Nathan DM, Wexler DJ.

Obesity (Silver Spring). 2015 Sep;23(9):1792-9. doi: 10.1002/oby.21172. Epub 2015 Aug 11.

39.

Delayed Gastric Emptying Is Associated With Early and Long-term Hyperglycemia in Type 1 Diabetes Mellitus.

Bharucha AE, Batey-Schaefer B, Cleary PA, Murray JA, Cowie C, Lorenzi G, Driscoll M, Harth J, Larkin M, Christofi M, Bayless M, Wimmergren N, Herman W, Whitehouse F, Jones K, Kruger D, Martin C, Ziegler G, Zinsmeister AR, Nathan DM; Diabetes Control and Complications Trial–Epidemiology of Diabetes Interventions and Complications Research Group.

Gastroenterology. 2015 Aug;149(2):330-9. doi: 10.1053/j.gastro.2015.05.007. Epub 2015 May 14.

40.

Intensive diabetes therapy and ocular surgery in type 1 diabetes.

DCCT/EDIC Research Group, Aiello LP, Sun W, Das A, Gangaputra S, Kiss S, Klein R, Cleary PA, Lachin JM, Nathan DM.

N Engl J Med. 2015 Apr 30;372(18):1722-33. doi: 10.1056/NEJMoa1409463.

41.

Saul Genuth, MD: clinical researcher and leader in developing modern diabetes treatment.

Jacobson AM, Nathan DM.

Diabetes Care. 2015 Mar;38(3):347-51. doi: 10.2337/dc14-1396. No abstract available.

PMID:
25715411
42.

Changes in body composition over 8 years in a randomized trial of a lifestyle intervention: the look AHEAD study.

Pownall HJ, Bray GA, Wagenknecht LE, Walkup MP, Heshka S, Hubbard VS, Hill J, Kahn SE, Nathan DM, Schwartz AV, Johnson KC; Look AHEAD Research Group.

Obesity (Silver Spring). 2015 Mar;23(3):565-72. doi: 10.1002/oby.21005.

43.

Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.

Writing Group for the DCCT/EDIC Research Group, Orchard TJ, Nathan DM, Zinman B, Cleary P, Brillon D, Backlund JY, Lachin JM.

JAMA. 2015 Jan 6;313(1):45-53. doi: 10.1001/jama.2014.16107.

44.

Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC.

Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group, Lachin JM, White NH, Hainsworth DP, Sun W, Cleary PA, Nathan DM.

Diabetes. 2015 Feb;64(2):631-42. doi: 10.2337/db14-0930. Epub 2014 Sep 9.

45.
46.

Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes.

Espeland MA, Glick HA, Bertoni A, Brancati FL, Bray GA, Clark JM, Curtis JM, Egan C, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Hazuda HP, Hill JO, Hire D, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Killean T, Kitabchi AE, Knowler WC, Kriska A, Lewis CE, Miller M, Montez MG, Murillo A, Nathan DM, Nyenwe E, Patricio J, Peters AL, Pi-Sunyer X, Pownall H, Redmon JB, Rushing J, Ryan DH, Safford M, Tsai AG, Wadden TA, Wing RR, Yanovski SZ, Zhang P; Look AHEAD Research Group.

Diabetes Care. 2014 Sep;37(9):2548-56. doi: 10.2337/dc14-0093.

47.

Baseline levels, and changes over time in body mass index and fasting insulin, and their relationship to change in metabolic trait clustering.

Rutter MK, Sullivan LM, Fox CS, Wilson PW, Nathan DM, Vasan RS, D'Agostino RB Sr, Meigs JB.

Metab Syndr Relat Disord. 2014 Sep;12(7):372-80. doi: 10.1089/met.2013.0148. Epub 2014 Jul 9.

48.

Outpatient glycemic control with a bionic pancreas in type 1 diabetes.

Russell SJ, El-Khatib FH, Sinha M, Magyar KL, McKeon K, Goergen LG, Balliro C, Hillard MA, Nathan DM, Damiano ER.

N Engl J Med. 2014 Jul 24;371(4):313-325. doi: 10.1056/NEJMoa1314474. Epub 2014 Jun 15.

49.

A comparative effectiveness analysis of three continuous glucose monitors: the Navigator, G4 Platinum, and Enlite.

Damiano ER, McKeon K, El-Khatib FH, Zheng H, Nathan DM, Russell SJ.

J Diabetes Sci Technol. 2014 Jul;8(4):699-708. doi: 10.1177/1932296814532203. Epub 2014 Apr 21.

50.

Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial.

Rubin RR, Wadden TA, Bahnson JL, Blackburn GL, Brancati FL, Bray GA, Coday M, Crow SJ, Curtis JM, Dutton G, Egan C, Evans M, Ewing L, Faulconbridge L, Foreyt J, Gaussoin SA, Gregg EW, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Knowler WC, Lang W, Lewis CE, Montez MG, Murillo A, Nathan DM, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Rejeski WJ, Rosenthal RH, Ruelas V, Toledo K, Van Dorsten B, Vitolins M, Williamson D, Wing RR, Yanovski SZ, Zhang P; Look AHEAD Research Group.

Diabetes Care. 2014 Jun;37(6):1544-53. doi: 10.2337/dc13-1928.

Supplemental Content

Loading ...
Support Center